So-Young International Inc. - American Depository Shares (SY)
2.9100
+0.5100 (21.25%)
NASDAQ· Last Trade: Aug 31st, 5:20 PM EDT
Detailed Quote
Previous Close
2.400
Open
2.740
Bid
2.810
Ask
2.950
Day's Range
2.464 - 3.020
52 Week Range
1.280 - 4.750
Volume
14,191,324
Market Cap
204.32M
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
0.0270 (0.93%)
1 Month Average Volume
169,142
Chart
About So-Young International Inc. - American Depository Shares (SY)
So-Young International Inc is a leading online healthcare platform in China that focuses on the rapidly growing medical aesthetics industry. The company connects users with a network of healthcare providers by offering services such as information sharing, patient reviews, and a platform to book medical aesthetic procedures. So-Young utilizes innovative technology to streamline the process of finding and evaluating treatments, ensuring that patients have access to reliable information and trusted providers. Through its digital ecosystem, the company enhances patient experiences while supporting clinics in attracting and retaining clients. Read More
Gainers Antelope Enterprise Hldgs (NASDAQ:AEHL) shares increased by 82.4% to $6.46 during Monday's regular session. The company's market cap stands at $4.0 million. So-Young Intl (NASDAQ:SY) shares moved
So-Young International (NASDAQ:SY) reported record quarterly revenue for the second quarter of 2026, driven by continued rapid growth in its aesthetic treatment services business, while its net loss narrowed from a year earlier.
Total revenue rose 33% year over year to about RMB510 million, accordi
So-Young International (NASDAQ:SY) reported sharply higher first-quarter 2026 revenue, driven by rapid growth in its branded aesthetic center business, while management said the company is continuing to expand its clinic footprint and invest in standardized medical delivery.
Total revenue rose 45.6
So-Young International (NASDAQ:SY) reported Q2 2025 results with revenue beating estimates but EPS missing badly, sending shares down 6.2% pre-market. Analysts see potential Q3 recovery.
